Home · Peptides · Vladonix
THE PEPTIDE APP FIELD GUIDE · Longevity SERIES FIELD SPECIMEN
Longevity CATEGORY

Vladonix

THE OVARIAN RESTORER

A-6 Thymus Bioregulator Peptide

Vladonix is a bioregulator peptide derived from thymus tissue that restores immune balance during aging. It supports T-cell maturation and differentiation, reduces chronic inflammation, and strengthens your body's defense mechanisms. Particularly valuable for people experiencing immune decline with age.

Vladonix
Vladonix
Vladonix

Vladonix Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Vladonix

◆

Is Vladonix FDA approved?

No. This profile records Vladonix as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Vladonix?

Dose: 20 mg daily (oral or sublingual).

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Vladonix guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Thymic Epithelial Support

Promotes FOXN1 and AIRE expression for proper T-cell education

Cytokine Balance

Reduces TNF-α, IL-1β, IL-6 while increasing IL-10 and TGF-β1

Immune Surveillance

Enhances perforin and granzyme B in cytotoxic cells

People with age-related immune decline
Those with recurrent infections
Anyone recovering from chemotherapy or illness
People with chronic inflammatory conditions

Vladonix Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.